Pharmacovigilance et COVID-19 : État des lieux et perspectives
| dc.contributor.advisor | Abdelhamid ZRARA | |
| dc.contributor.author | Hanane EL HARRIF | |
| dc.date.accessioned | 2023-09-15T13:42:34Z | |
| dc.date.accessioned | 2026-01-22T13:34:25Z | |
| dc.date.available | 2023-09-15T13:42:34Z | |
| dc.date.issued | 2022 | |
| dc.description.collaborator | El Arbi BOUAITI | |
| dc.description.collaborator | Yassir BOUSLIMAN | |
| dc.description.collaborator | Mohamed Rida TAGAJDID | |
| dc.description.collaborator | Ahmed REGGAD | |
| dc.identifier.uri | https://toubkal.imist.ma/handle/123456789/19267 | |
| dc.identifier.uri | https://doi.org/10.83129/toubkal-13846 | |
| dc.language.iso | FR | |
| dc.publisher | Université Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabat | fr_FR |
| dc.subject | Revue systématique | fr_FR |
| dc.subject | Pharmacovigilance | fr_FR |
| dc.subject | COVID-19 | fr_FR |
| dc.subject | Vaccins | fr_FR |
| dc.subject | Traitement | fr_FR |
| dc.subject.other | Sciences médicales | |
| dc.subject.specific | Pharmacie | |
| dc.title | Pharmacovigilance et COVID-19 : État des lieux et perspectives | fr_FR |
Files
Original bundle
1 - 1 of 1